Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children
NCT ID: NCT03551236
Last Updated: 2018-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2017-01-17
2017-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Normal Variability of Tidal Breathing Flow-volume Curves During Sleep in Healthy Children
NCT03785847
Identification of Sleep-Disordered Breathing in Children
NCT00233194
Prevalence and Correlates of Childhood Sleep Apnea
NCT00005560
The Use of Psychomotor Vigilance Testing in the Assessment of Pediatric Obstructive Sleep Apnea
NCT01276860
Cerebral Blood Flow and Childhood Obstructive Sleep Apnea
NCT02995837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy at the time of inclusion
* Laboratory analyses in the reference range or not clinically relevant according to the investigator judgement
* Lung function in the reference range with a negative bronchodilator test result
* Signed informed consent
Exclusion Criteria
* Chronic respiratory disorder of prematurity
* Recurrent bronchitis or recurrent hospitalizations because of a respiratory illness (recurrent pneumonia)
* Primary immunodeficiency
* Chronic rhinosinusitis, synonasal polyposis
* Nasal congestion, adenotonsillar hypertrophy, signs and symptoms of sleep apnea or sleep disordered breathing
* Acute respiratory infection or hospitalization because of an acute illness within 4 weeks prior to inclusion
* Personal or family history or clinical evidence of asthma, atopy or other chronic respiratory disorders (high risk for asthma and allergy)
* Use of asthma rescue or maintenance medication within 4 weeks prior to inclusion
* Implanted or external active medical devices such as pacemakers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Srebrnjak
OTHER
Revenio Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davor Plavec, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Srebrnjak
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Srebrnjak
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VCS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.